Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.
Saved in:
| Title: | Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. |
|---|---|
| Authors: | Schultz SA; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Shirzadi Z; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Schultz AP; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Liu L; Brigham and Women's Hospital, Boston, Massachusetts, USA.; Ann Romney Center for Neurologic Diseases, Boston, Massachusetts, USA., Fitzpatrick CD; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., McDade E; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Barthelemy NR; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Renton A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Esposito B; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Joseph-Mathurin N; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Cruchaga C; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Chen CD; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Goate A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Allegri RF; INEBA, Buenos Aires, Argentina., Benzinger TLS; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Berman S; University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Chui HC; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Fagan AM; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Farlow MR; Indiana Alzheimer's Disease Research Center, Indianapolis, Indiana, USA., Fox NC; Dementia Research Centre & UK Dementia Research Institute, UCL Institute of Neurology, London, UK., Gordon BA; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Day GS; Mayo Clinic, Jacksonville, Florida, USA., Graff-Radford NR; Mayo Clinic, Jacksonville, Florida, USA., Hassenstab JJ; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Hanseeuw BJ; Institute of Neuroscience, UCLouvain, Brussels, Belgium.; Gordon Center for Medical Imaging in the Radiology Department of MGH, Boston, Massachusetts, USA., Hofmann A; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany., Jack CR Jr; Mayo Clinic, Rochester, Minnesota, USA., Jucker M; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany., Karch CM; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Koeppe RA; University of Michigan, Ann Arbor, Michigan, USA., Lee JH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Levey AI; Emory Goizueta Alzheimer's Disease Research Center, Atlanta, Georgia, USA., Levin J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Martins RN; Edith Cowan University, Joondalup, Western Australia, Australia., Mori H; Osaka City University Medical School, Osaka, Japan., Morris JC; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Noble J; Columbia University, New York, New York, USA., Perrin RJ; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Rosa-Neto P; Translational Neuroimaging Laboratory, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest-de-l'Île-de-Montréal; Department of Neurology and Neurosurgery, McGill University, Montreal, Canada., Salloway SP; Butler Hospital, Providence, Rhode Island, USA., Sanchez-Valle R; Alzheimer's disease and other cognitive disorders Unit, Neurology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomediques, Barcelona, Spain., Schofield PR; Neuroscience Research Australia, Randwick, New South Wales, Australia.; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia., Xiong C; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Johnson KA; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA., Bateman RJ; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA., Sperling RA; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA., Chhatwal JP; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA. |
| Corporate Authors: | Dominantly Inherited Alzheimer Network Investigators |
| Source: | Aging cell [Aging Cell] 2023 Aug; Vol. 22 (8), pp. e13871. Date of Electronic Publication: 2023 Jun 08. |
| Publication Type: | Observational Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101130839 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-9726 (Electronic) Linking ISSN: 14749718 NLM ISO Abbreviation: Aging Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1474-9726 |
|---|---|
| DOI: | 10.1111/acel.13871 |
